Article Information
History
- June 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vanille Simon1,
- Lucie Laot1,
- Enora Laas1,
- Sonia Rozette2,
- Julien Guerin3,
- Thomas Balezeau3,
- Marion Nicolas1,
- Jean-Yves Pierga2,
- Florence Coussy2,
- Marick Laé4,
- Diane de Croze4,
- Beatriz Grandal1,5,
- Judith Abecassis5,
- Fabien Reyal1,5,* and
- Anne-Sophie Hamy1,5
- 1Department of Surgical Oncology, Institut Curie, Paris, France; University Paris, Paris France
- 2Department of Medical Oncology, Institut Curie, Paris, France; University Paris, Paris France
- 3Data factory - Institut Curie, 26 rue d’Ulm, 75005 Paris, France
- 4Department of Tumor Biology, Institut Curie, France
- 5Residual Tumor & Response to Treatment Laboratory, RT2Lab, translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d’Ulm, Paris, France
- ↵*Corresponding author; email: fabien.reyal{at}gmail.com